PMC:7029759 / 35572-35728 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"930","span":{"begin":0,"end":4},"obj":"Gene"}],"attributes":[{"id":"A930","pred":"tao:has_database_id","subj":"930","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ACE2-Fc would be resistant to viral escape as well, unlike potential neutralizing monoclonal antibodies that may be developed in the coming weeks to months."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T681","span":{"begin":0,"end":4},"obj":"G_3;PG_10;PR:000003622"},{"id":"T680","span":{"begin":30,"end":35},"obj":"NCBITaxon:10239"},{"id":"T679","span":{"begin":93,"end":103},"obj":"GO:0042571"}],"text":"ACE2-Fc would be resistant to viral escape as well, unlike potential neutralizing monoclonal antibodies that may be developed in the coming weeks to months."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T371","span":{"begin":5,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"ACE2-Fc would be resistant to viral escape as well, unlike potential neutralizing monoclonal antibodies that may be developed in the coming weeks to months."}

{"project":"LitCovid-sentences","denotations":[{"id":"T221","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACE2-Fc would be resistant to viral escape as well, unlike potential neutralizing monoclonal antibodies that may be developed in the coming weeks to months."}